Please assess the completion status of the following clinical trial:

Trial Title: Bypass or Thurpass for Superficial Femoral Artery Occlusion? Scandinavian Thurpass Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Superficial femoral artery occlusion from 5 to 25 cm in length above the knee joint.~2. Patient must be equally eligible for both procedures.~3. Patient must present intermittent claudication with resistance to medical therapy and exercise or critical ischaemia.~4. Normal adjacent vessel diameter must be between 4.8 and 6.5 mm.~5. At least one patent distal run-off vessel and at least 1 cm of healthy superficial femoral artery below and above the lesion to allow proper placement of the endoprosthesis.~6. Patient must be 18 years or older.~7. Women of childbearing age must have negative pregnancy test prior to inclusion.~Exclusion Criteria:~1. Known allergy or contraindications to aspirin, clopidogrel, dipyridamole or anticoagulants.~2. Bleeding diatheses~3. Presence of one or several previously placed endoprosthesis or grafts in the superficial femoral artery segment.~4. Planned other endovascular therapy of the same segment.~5. Other than 6-7 mm diameter endoprosthesis or 6 mm PTFE-prosthesis is needed.~6. Presence of evolving malignant cancer or any other illness posing an immediate threat to life.~7. Life-expectancy less than 2 years due to co-morbidity or other situation that would make the patient unlikely candidate for follow-up visits.~8. Participation in another vascular clinical study less than 30 days prior to inclusion.~9. Patients unable to fill out the prescribed quality of life questionnaires themselves or unable to understand the full meaning of the informed consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Thrupass (Type: OTHER): Endovascular treatment (Thrupass) is performed as a femoropopliteal above knee endovascular recanalisation and Viabahn introduction with 6-7 mm Viabahn endo-prosthesis.
- Bypass (Type: OTHER): Surgical procedure is performed as a femoropopliteal above knee by-pass with 6 mm non-coated PTFE-graft

Based on this trial design, predict the completion outcome and termination type (if applicable).